Targeted cancer therapies are drugs or other substances that block the growth and spread of cancer by interfering with specific molecules (“molecular targets”) that are involved in the growth, progression, and spread of cancer. Targeted cancer therapies are sometimes called “molecularly targeted drugs,” “molecularly targeted therapies,” “precision medicines,” or similar names. Targeted therapies are currently the focus of much anticancer drug development. They are a cornerstone of precision medicine, a form of medicine that uses information about a person’s genes and proteins to prevent, diagnose, and treat disease. Many targeted cancer therapies have been approved by the Food and Drug Administration (FDA) to treat specific types of cancer. Others are being studied in clinical trials (research studies with people), and many more are in preclinical testing (research studies with animals).
In the present book, fifteen typical literatures about targeted cancer therapies published on international authoritative journals were selected to introduce the worldwide newest progress, which contains reviews or original researches on medical science, bioinformatics, oncology, epidemiology, ect. We hope this book can demonstrate advances in targeted cancer therapies as well as give references to the researchers, students and other related people.